Revium Rx
Advanced Lipid-based Platform
StartupRevium Rx is a Herzliya-based startup in the Health Tech & Life Sciences sector, established in 2021. Advanced Lipid-based Platform. Revium Rx was founded by Inna Martin. The company has 1-10 employees.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQHerzliya
- DistrictCenter District
- Last RoundUndisclosed
Inna MartinCOO & President
4 articles covered by sources including www.calcalistech.com,
www.calcalist.co.il,
csimarket.com,
www.globenewswire.com.
What does Revium Rx do?
Revium Rx develops advanced delivery systems for a variety of indications. Its platform expands the therapeutic horizons of hard-to-treat diseases by enhancing, improving and unleashing the potential of encapsulated therapeutics. Revium’s current pipeline encompasses antibiotics for antimicrobial-resistant bacteria, immune checkpoint inhibitor adjuvant for solid tumors, and a novel immunization platform.
Who founded Revium Rx?
Revium Rx was founded in 2021 by Inna Martin (COO & President).
What sector is Revium Rx in?
Revium Rx operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery. Target customers: Healthcare & Life Sciences, Healthcare, Patients.
Where is Revium Rx located?
Revium Rx is based in HaMenofim Street 10, Herzliya, Israel, Center District.